Zealand Pharma’s Amylin Analog ZP8396 Shows Promise for Overcoming Obesity Challenges

Zealand Pharma’s Amylin Analog ZP8396 Shows Promise for Overcoming Obesity Challenges

Zealand Pharma, a biotechnology company, presented data for their amylin analog ZP8396 at the Obesity Society Annual Meeting (ObesityWeek) in…

Read More »